Sign In
Buy SNY
$43.98
-0.680 (-1.52%)
At Close: Jul 20, 2026
Sanofi to acquire U.S. biopharmaceutical group Kadmon in $1.9 billion deal
01:31am, Wednesday, 08'th Sep 2021
French pharmaceutical major Sanofi SA said Wednesday that it has entered into a definitive agreement to acquire U.S.-based biopharmaceutical company Kadmon Holdings Inc.
France's Sanofi to buy U.S. biopharma firm Kadmon in $1.9 billion deal
01:15am, Wednesday, 08'th Sep 2021
French drugmaker Sanofi SA has agreed to buy U.S. biopharmaceutical company Kadmon Holdings Inc in a $1.9 billion deal, the companies said on Wednesday.
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
02:00pm, Tuesday, 31'st Aug 2021
August proved to be a mixed month for regulatory approvals, with the Food and Drug Administration approving a few, turning down a few others and delaying the remaining. New molecular entity approvals
Sanofi (SNY)/Regeneron's Dupixent Meets Eczema Study Goal
12:10pm, Monday, 30'th Aug 2021
Sanofi (SNY) and Regeneron (REGN)'s Dupixent meet all primary and secondary endpoints in phase III study to treat children aged six months to five years with moderate-to-severe atopic dermatitis.
Which Biotech Stock Will Shock the Market in 2022?
10:40am, Friday, 27'th Aug 2021
Over the last few years, three tiny biotechs emerged out of nowhere to give amazing returns to early investors. Which biotech might pull off a similar feat in 2022?
House Committee Questions Eli Lilly, Sanofi, Novo Nordisk On 'Unacceptably High' Insulin Prices
02:34pm, Friday, 20'th Aug 2021
House Energy & Commerce Committee leaders sent three letters to execs at Eli Lilly And Co (NYSE: LLY), Sanofi SA (NASDAQ: SNY), and Novo Nordisk A/S (NYSE: NVO), raising concerns that despite
Surprise! Here's the Cheapest COVID Vaccine Stock on the Market Right Now
05:52am, Thursday, 19'th Aug 2021
The least expensive COVID-19 vaccine stock right now isn't one of the leaders in the market -- at least not yet.
Inside Sanofi's $3.2B Translate Bio Buyout
04:19pm, Monday, 16'th Aug 2021
Before the $3.2 billion acquisition of mRNA player Translate Bio Inc (NASDAQ: TBIO) earlier this month, Sanofi SA (NASDAQ: SNY) expressed interest in selling off around 25% of its shares in the
3 Best Biotech Stocks To Buy for Upcoming Catalysts
06:00am, Thursday, 12'th Aug 2021
The next few months are critical for these biotech stocks which could witness a massive increase in their stock prices this year The post 3 Best Biotech Stocks To Buy for Upcoming Catalysts appeared f
Sanofi (SNY) Pompe Disease Drug Receives FDA's Approval
01:53pm, Monday, 09'th Aug 2021
The FDA gives approval to Sanofi's (SNY) Nexviazyme (avalglucosidase alfa) for treating late-onset Pompe disease.
Sanofi - Regeneron's Libtayo/Chemo Treatment Improves Overall Survival First-Line Lung Cancer
09:18am, Thursday, 05'th Aug 2021
The Phase 3 trial of Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) Libtayo in combination with platinum-doublet chemotherapy was stopped early after meeting its overa
Analysis-Sanofi's COVID-19 vaccine setback, drug pipeline cast long shadow
02:19am, Thursday, 05'th Aug 2021
Pharmaceutical company Sanofi remains under pressure to launch new drugs and overcome setbacks in the COVID-19 vaccine race, despite a $3.2 billion deal to tighten its grip on promising mRNA technolog
Sanofi to Buy mRNA Developer: ETFs in Focus
04:01pm, Wednesday, 04'th Aug 2021
Sanofi has agreed to acquire U.S. biotech company Translate Bio to gain exposure in the mRNA vaccine space.
The 102 Most Reliable Dividends On Earth For August
10:17am, Wednesday, 04'th Aug 2021
Kiplinger "insights for investors" online first offered a list of 91 "Top Dividend Stocks From Around The World" 7/13/20. Two recent Kiplinger articles provided 102 Top Dividend Stocks on Earth list 7
Delta Variant Surge Brings Biotech ETFs in Focus
06:18pm, Tuesday, 03'rd Aug 2021
The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.
